Alvotech (ALVO)
NASDAQ · Health Care · Biological Products, (No Diagnostic Substances)
Biological Products, (No Diagnostic Substances) company based in Luxembourg, Luxembourg. Foreign private issuer: reports on Form 20-F or 40-F. Its directors and officers file insider-trading forms (Form 4) only since 18 March 2026.
As of Oct 29, 2026, OQRO holds for Alvotech (ALVO) over the last 12 months: 0 insider filings, 0 Congress trades, 1 fund position and 0 federal contract awards. Most recent on file: Rubric Capital Management LP disclosed a new position in ALVO for Q2 2026, filed Aug 14, 2026.
Example public filing
Rubric Capital Management LP opened a new position $57.8M
Rubric Capital Management LP opened a new position in Alvotech, per its Q2 2026 13F.
- 15.7M
- Shares reported
- 0.53%
- Disclosed portfolio weight
- $57.8M
- Reported value
- Holdings as of
- Jun 30, 2026
- Filed
- Aug 14, 2026
Data as of Oct 29, 2026. A real record from the official source, chosen as the most recent insider trade or, failing that, the most recent filing of another kind; not a recommendation.
On file for ALVO, last 12 months
- 0
- Insider filings
- 0
- Congress trades
- 1
- Fund positions
- 0
- Federal contracts
Records OQRO holds, counted by their date; a 13F position is counted once per quarter it is reported.
See the full picture with OQRO Pro.
1 record for Alvotech in the last 12 months, each linked to its filing. Full histories, the screener, alerts for the companies you follow and Ask OQRO.
Latest disclosures
3 days free for first-time subscribers, then $9.99 a month. Nothing is charged today: your card is charged when the trial ends unless you cancel before, from your account. Secure payment by Stripe.
Public previews are free. Full research is OQRO Pro, with a 3-day free trial to start: your card is charged only when the trial ends.
Free account: get the written context of this page, built from its filings.
What this page holds
- Insider trades and planned sales
- Politician trades (House and Senate)
- Fund holdings from 13F filings
- Federal contracts, lobbying and short selling
- Full history and context, with a link to every filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Alvotech insider trading
Have Alvotech insiders bought shares recently?
No open-market purchase by an insider of Alvotech is on record in SEC filings since 2006.
Do members of Congress trade ALVO?
No trade in Alvotech (ALVO) was disclosed by a member of Congress in the last 12 months.
When does Alvotech report its next results?
Alvotech's next results are expected on Nov 11, 2026. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.